Mass spectrometry-based proteomics techniques and their application in ovarian cancer research
Abstract Ovarian cancer has emerged as one of the leading cause of gynecological malignancies. So far, the measurement of CA125 and HE4 concentrations in blood and transvaginal ultrasound examination are essential ovarian cancer diagnostic methods. However, their sensitivity and specificity are stil...
Saved in:
Main Authors: | Agata Swiatly (Author), Szymon Plewa (Author), Jan Matysiak (Author), Zenon J. Kokot (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2018-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular response to PARP1 inhibition in ovarian cancer cells as determined by mass spectrometry based proteomics
by: Alexandra Franz, et al.
Published: (2021) -
Free Amino Acid Alterations in Patients with Gynecological and Breast Cancer: A Review
by: Dagmara Pietkiewicz, et al.
Published: (2021) -
Discovery of potential ovarian cancer biomarkers using low molecular weight blood plasma proteome profiling by mass spectrometry
by: V. E. Shevchenko, et al.
Published: (2014) -
Mass Spectrometry-based Serum Proteome Pattern Analysis in Prophylactic Oophorectomy
by: Lukkana Promwattanaphan, et al.
Published: (2015) -
Unveiling Tumorigenesis Mechanisms and Drug Therapy in Neuroblastoma by Mass Spectrometry Based Proteomics
by: Keyi Ren, et al.
Published: (2024)